Clinical trial
A Double-Blind, Randomized, Placebo-Controlled Trial of Xenon Inhalation for Treatment of Patients With Panic Disorder
NCT04432155 is registered in ClinicalTrials.gov with Nobilis Therapeutics Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Randomized, Placebo-Controlled Trial of Xenon Inhalation for Treatment of Patients With Panic Disorder
- Lead sponsor
- Nobilis Therapeutics Inc.
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- June 30, 2021
- Completion date
- December 31, 2021
- Enrollment
- 200 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.